ThursdayOct 26, 2023 10:54 am

QualityStocksNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Brings Sustainable Solution for Rising Demand in ‘Rattiest Cities’

A recent Fox Business article discussed pest control company Orkin’s annual ranking of the “Top 50 Rattiest Cities,” where Chicago continues to top the list, followed by Los Angeles, New York City, Washington, D.C., and San Francisco. Rankings are based on the number of new rodent services showcasing the demand and efforts that residents and businesses of the top cities have taken to treat rodent issues. Among these are strategies such as cutting off rats’ food sources and developing new technologies to detect and exterminate rat populations. As an expert in animal fertility control and the inventor of the only…

Continue Reading

ThursdayOct 26, 2023 10:05 am

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Inks 2024 Media Contract with ‘New to the Street’ Program

Sekur Private Data (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, is partnering with FMW Media Corp.’s “New to the Street,” one of the longest-running syndicated Nielsen-rated programming television brands. Sekur has signed a media contract with the platform; the agreement covers television airings and other multimedia content and streaming. According to the announcement, “New to the Street” will continue filming interviews with SWISF CEO Alain Ghiai, including the popular “Sekur Privacy & Sekur Security — The Weekly Hack” segment, which features Ghiai and host Ana Berry discussing key cybersecurity risks along with Sekur solutions. The…

Continue Reading

WednesdayOct 25, 2023 3:20 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Schedules Q3 2023 Earnings Call

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, has announced plans to report on its third-quarter financial results for the period ended Sept. 30, 2023. The company will issue its third quarter earnings press release before market opens on Nov. 9, 2023. In addition, D-Wave Quantum CEO Alan Baratz and CFO John Markovich will host a conference call on the same day; the call will begin at 8 a.m. ET. During the call, company officials will discuss D-Wave Quantum financial results as well as its business outlook. Those interested can access by call by dialing…

Continue Reading

WednesdayOct 25, 2023 12:52 pm

QualityStocksNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Featured in Bell2Bell Podcast

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company working to advance the next generation of high quality nickel sulphide projects to feed the high growth electric vehicle and stainless steel markets, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Mark Selby, CEO and director of Canada Nickel, joined the latest episode to discuss the company’s projects, including its recent news announcing the positive bankable feasibility study for its Crawford Nickel Sulphide Project. “It’s a major milestone for the company – $2.5 billion after-tax…

Continue Reading

WednesdayOct 25, 2023 12:05 pm

QualityStocksNewsBreaks – Safety Shot (NASDAQ: SHOT) Granted Second U.S. Patent for JW-700 Treatment Designed for $1.5B Hair-Growth Market

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, announced a “significant milestone” in its development of treatments for androgenetic alopecia, or hair loss: the granting of a second U.S. patent issued for JW-700, a topical treatment designed to improve minoxidil’s efficacy. The patent was issued by the U.S. Patent and Trademark Office. The patent adds to the growing global intellectual property (“IP”) estate for Safety Shots Legacy products. According to the announcement, minoxidil is a common treatment of hair loss sold under brand names including Rogaine(R) and Hair Regrowth for Men(R), and Safety Shot’s JW-700 has been shown to…

Continue Reading

WednesdayOct 25, 2023 10:45 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Agreements for Private Placement, Preferred Investment Options

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, has entered into a definitive agreement for the issue and sale of more than 3 million common shares, or prefunded warrants in lieu thereof. Specifically, the company agreed to a private placement of 3,012,049 common shares priced at $0.83 per share. In addition, the company entered an agreement for an associated preferred investment option as well as a definitive agreement regarding specific outstanding preferred investment options issued in November 2022. The announcement outlines specifics of the agreement. The company also…

Continue Reading

TuesdayOct 24, 2023 12:20 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positive Proof-of-Concept Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced its selection of a lead Alzheimer’s disease drug candidate, named INM-901, following positive results from several proof-of-concept studies in a validated Alzheimer’s treatment model. InMed will be advancing cannabinoid analog INM-901 in its pharmaceutical drug development program. “The most recent studies of INM-901 demonstrate promising disease-modifying effects in an Alzheimer’s disease treatment model,” said Dr. Eric Hsu, InMed’s SVP of preclinical research and development. “We are optimistic that the next stage of studies will continue to show how…

Continue Reading

TuesdayOct 24, 2023 12:09 pm

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Top-Line Results from Phase 2a Trial Spotlighted in Latest NNA Release

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, is featured in a recent NetworkNewsAudio (“NNA”) broadcast. The segment focuses on the company’s most recent announcement of its topline results from the CLEAR Mind phase 2a clinical trial of LGVN’s Lomecel-B(TM) for the treatment of mild Alzheimer's disease. According to the segment, the Lomecel-B study met its primary safety endpoint and is supported by lack of deterioration in cognitive or atrophy signals. The encouraging results will be used as a foundation…

Continue Reading

TuesdayOct 24, 2023 11:41 am

QualityStocksNewsBreaks – GEMXX Corporation (GEMZ) Releases Gold Production Report for BC-Based Snow Creek Test Mine Site

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment and a 50% partner in Canadian gold-exploration company Crazy Horse Mining Inc. (“CHMI”), has successfully completed its third and final clean-out and recording of gold production at the Snow Creek Mine site for the 2023 mining season. According to the announcement, GEMXX and CHMI have processed 31,200 cubic yards of gold-bearing ore during the 2023 test season; those results met all expectations, the report noted, and are positive considering much of the material used during the test program was surface “gold bearing ore” that had been stockpiled when making…

Continue Reading

TuesdayOct 24, 2023 11:03 am

QualityStocksNewsBreaks – Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) Executes Initial Drill Program at Ruby Graphite Project

Reflex (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) today announced completion of its 2023 phase one drill program at its Ruby Graphite Project near Dillon, Montana. The program’s impressive efficiencies allowed the company to complete 22 holes, surpassing the originally planned 16 holes, with all reaching an average depth of 150 meters. The company’s geological team is now focused on data compilation, with assay results expected in the first quarter of 2024. “The team is very pleased with how much we have been able to accomplish during phase one of our drill program,” said Paul Gorman, CEO of Reflex Advanced Materials.…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered